Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-12-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于公司申请向不特定对象发行可转换公司债券审核问询函回复（修订稿）的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding its response to an inquiry letter from the Shenzhen Stock Exchange about its application to issue convertible bonds to unspecified investors. It references updates to financial data as of the third quarter of 2021 but does not contain the financial data itself. The document mainly discusses regulatory review and the company's reply to the inquiry, including references to filings on a public information website. The document is short (979 characters) and serves as a notice about the status and updates related to a capital raising process, specifically convertible bond issuance. It is not a full financial report, earnings release, or audit report. It is an update on financing activities and regulatory review related to capital raising. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-12-15 Chinese
北京市长安律师事务所关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券之补充法律意见书（一）（修订稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding a company's issuance of convertible bonds to unspecified investors. It includes extensive legal analysis, responses to regulatory inquiries, and detailed information about the company's business, market position, and compliance with antitrust laws. The document references specific regulatory inquiries, legal standards, and the company's financial and operational data. It is not a financial report like an annual or quarterly report, nor is it a simple announcement or certification. It is a specialized legal opinion related to a capital market transaction (issuance of convertible bonds). Given the content focuses on legal opinions and regulatory compliance related to financing activities, the most appropriate classification is "Capital/Financing Update (CAP)".
2021-12-15 Chinese
公司与中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司申请向不特定对象发行可转换公司债券的审核问询函的回复（修订稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed response to a regulatory inquiry from the Shenzhen Stock Exchange regarding the company's application to issue convertible bonds to unspecified investors. It contains extensive financial data, sales figures, operational details, and risk disclosures related to the company's recent performance and business operations. The document is lengthy (15,000 characters) and includes substantive financial and operational analysis, not merely an announcement or certification. It is not a full annual report but rather a regulatory response document with detailed financial and operational disclosures related to a capital market transaction (issuance of convertible bonds). This type of document aligns best with the category of Capital/Financing Update (CAP), as it pertains to the company's financing activities and includes detailed financial and operational information supporting that activity.
2021-12-15 Chinese
康泰医学系统（秦皇岛）股份有限公司创业板向不特定对象发行可转换公司债券募集说明书（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书（修订稿）" which translates to "Offering Circular (Revised Draft)" for a convertible bond issuance by 康泰医学系统（秦皇岛）股份有限公司. It contains detailed information about the issuance of convertible bonds, compliance with regulatory requirements, credit ratings, risk factors, profit distribution policies, and other related financial and operational details. The document is lengthy (15,000 characters) and contains substantive financial and operational data related to the capital raising activity. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. It is not an announcement of a report, nor a full annual or interim report, but a detailed offering document related to a financing event. Therefore, the correct classification is CAP with high confidence.
2021-12-15 Chinese
德勤华永会计师事务所(特殊普通合伙)《关于康泰医学系统(秦皇岛)股份有限公司申请向不特定对象发行可转换公司债券的审核问询函》相关问题回复之意见（修订稿）
Audit Report / Information Classification · 95% confidence The document is a detailed auditor's response from Deloitte Hua Yong CPA regarding Kangtai Medical System (Qinhuangdao) Co., Ltd.'s application for issuing convertible bonds to unspecified objects. It includes extensive financial data, sales breakdowns, audit opinions, and detailed explanations about sales processes, revenue recognition, and risk disclosures. The document references audited financial statements for multiple years and discusses the sustainability of business growth, market demand, and operational details. It is clearly an audit-related report addressing regulatory inquiries from the Shenzhen Stock Exchange concerning the company's financials and issuance application. The document is lengthy (15,000 characters) and contains substantive financial data and audit opinions, not merely an announcement or certification. Therefore, it fits the category of an Audit Report / Information (AR). 9M 2021
2021-12-15 Chinese
关于持股5%以上股东减持公司股份超过1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding a shareholder holding more than 5% reducing their stake by over 1%. It details the shareholder's name, the number of shares reduced, the percentage of total shares, and the method of reduction. It includes specific dates and percentages related to shareholding changes. This type of document is a notification of a major shareholding change, which fits the category of Major Shareholding Notification (MRQ). The document length is 2526 characters, which is typical for such announcements. There is no indication that this is a full financial report, audit, or other types of filings. Therefore, the correct classification is MRQ with high confidence.
2021-12-01 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.